442 related articles for article (PubMed ID: 31830587)
1. Biologics in chronic rhinosinusitis with nasal polyposis.
Laidlaw TM; Buchheit KM
Ann Allergy Asthma Immunol; 2020 Apr; 124(4):326-332. PubMed ID: 31830587
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
Okano M; Kanai K; Oka A
Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
[TBL] [Abstract][Full Text] [Related]
3. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
Kariyawasam HH
Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
[No Abstract] [Full Text] [Related]
4. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
Patel GB; Peters AT
Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
[TBL] [Abstract][Full Text] [Related]
5. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
6. Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
Mullur J; Buchheit KM
Ann Allergy Asthma Immunol; 2023 Sep; 131(3):317-324. PubMed ID: 37225000
[TBL] [Abstract][Full Text] [Related]
7. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
[TBL] [Abstract][Full Text] [Related]
8. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526
[TBL] [Abstract][Full Text] [Related]
9. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
Hardison SA; Senior BA
J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
[TBL] [Abstract][Full Text] [Related]
10. Use of biologics in chronic sinusitis with nasal polyps.
Wang C; Zhang L
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):365-372. PubMed ID: 31082822
[TBL] [Abstract][Full Text] [Related]
11. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
Geng B; Dilley M; Anterasian C
Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
[TBL] [Abstract][Full Text] [Related]
12. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
Brown WC; Senior B
Curr Allergy Asthma Rep; 2020 Apr; 20(6):16. PubMed ID: 32323067
[TBL] [Abstract][Full Text] [Related]
13. Is there a future for biologics in the management of chronic rhinosinusitis?
Lam K; Kern RC; Luong A
Int Forum Allergy Rhinol; 2016 Sep; 6(9):935-42. PubMed ID: 27103607
[TBL] [Abstract][Full Text] [Related]
14. A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis.
Lelegren MJ; Son SY; Han JK; Lam KK
Immunotherapy; 2022 Jun; 14(8):655-662. PubMed ID: 35510314
[TBL] [Abstract][Full Text] [Related]
15. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
[TBL] [Abstract][Full Text] [Related]
16. Targetable pathogenic mechanisms in nasal polyposis.
Schneider AL; Schleimer RP; Tan BK
Int Forum Allergy Rhinol; 2021 Aug; 11(8):1220-1234. PubMed ID: 33660425
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation.
Jin Z; Yan B; Zhang L; Wang C
Expert Opin Investig Drugs; 2023; 32(10):909-919. PubMed ID: 37855222
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives.
Li T; Yin J; Yang Y; Wang G; Zhang Y; Song X
Expert Rev Clin Immunol; 2023; 19(8):939-948. PubMed ID: 37378551
[TBL] [Abstract][Full Text] [Related]
20. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]